Insider Shareholders with Direct Ownership of Rubius Therapeutics, Inc. (RUBY)
This section provides a comprehensive overview of the insiders with direct ownership of Rubius Therapeutics, Inc. (RUBY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Rubius Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David R Epstein
Director |
30,000 | 125,441 | 4,720,012 $0 | 5 |
Apr 21, 2022
Added 0.63%
|
|
Pablo J Cagnoni
Director |
67,500 | 22,418 | 66,082 $0 | 6 |
Feb 01, 2023
Reduced 11.34%
|
|
Laurence A. Turka
Chief Scientific Officer |
23,501 | 5,110 | 18,391 $0 | 5 |
Jan 31, 2023
Reduced 12.36%
|
|
Maiken Keson Brookes
CLO & Corp. Secretary |
33,075 | 27,732 | 5,343 $0 | 4 |
Feb 01, 2022
Reduced 33.83%
|
|
Dannielle Appelhans
CEO and President |
20,000 | 20,000 | 0 $0 | 5 |
Feb 24, 2023
Reduced 100.0%
|